132 related articles for article (PubMed ID: 36211342)
1. Assessment of type I interferon signatures in undifferentiated inflammatory diseases: A Japanese multicenter experience.
Miyamoto T; Honda Y; Izawa K; Kanazawa N; Kadowaki S; Ohnishi H; Fujimoto M; Kambe N; Kase N; Shiba T; Nakagishi Y; Akizuki S; Murakami K; Bamba M; Nishida Y; Inui A; Fujisawa T; Nishida D; Iwata N; Otsubo Y; Ishimori S; Nishikori M; Tanizawa K; Nakamura T; Ueda T; Ohwada Y; Tsuyusaki Y; Shimizu M; Ebato T; Iwao K; Kubo A; Kawai T; Matsubayashi T; Miyazaki T; Kanayama T; Nishitani-Isa M; Nihira H; Abe J; Tanaka T; Hiejima E; Okada S; Ohara O; Saito MK; Takita J; Nishikomori R; Yasumi T
Front Immunol; 2022; 13():905960. PubMed ID: 36211342
[TBL] [Abstract][Full Text] [Related]
2. Contribution of the Unfolded Protein Response (UPR) to the Pathogenesis of Proteasome-Associated Autoinflammatory Syndromes (PRAAS).
Ebstein F; Poli Harlowe MC; Studencka-Turski M; Krüger E
Front Immunol; 2019; 10():2756. PubMed ID: 31827472
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of a novel type I interferonopathy due to a de novo PSMB9 gene mutation with a Janus kinase inhibitor.
Kataoka S; Kawashima N; Okuno Y; Muramatsu H; Miwata S; Narita K; Hamada M; Murakami N; Taniguchi R; Ichikawa D; Kitazawa H; Suzuki K; Nishikawa E; Narita A; Nishio N; Yamamoto H; Fukasawa Y; Kato T; Yamamoto H; Natsume J; Kojima S; Nishino I; Taketani T; Ohnishi H; Takahashi Y
J Allergy Clin Immunol; 2021 Aug; 148(2):639-644. PubMed ID: 33727065
[TBL] [Abstract][Full Text] [Related]
4. Mutations in proteasome subunit β type 8 cause chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature with evidence of genetic and phenotypic heterogeneity.
Liu Y; Ramot Y; Torrelo A; Paller AS; Si N; Babay S; Kim PW; Sheikh A; Lee CC; Chen Y; Vera A; Zhang X; Goldbach-Mansky R; Zlotogorski A
Arthritis Rheum; 2012 Mar; 64(3):895-907. PubMed ID: 21953331
[TBL] [Abstract][Full Text] [Related]
5. Additive loss-of-function proteasome subunit mutations in CANDLE/PRAAS patients promote type I IFN production.
Brehm A; Liu Y; Sheikh A; Marrero B; Omoyinmi E; Zhou Q; Montealegre G; Biancotto A; Reinhardt A; Almeida de Jesus A; Pelletier M; Tsai WL; Remmers EF; Kardava L; Hill S; Kim H; Lachmann HJ; Megarbane A; Chae JJ; Brady J; Castillo RD; Brown D; Casano AV; Gao L; Chapelle D; Huang Y; Stone D; Chen Y; Sotzny F; Lee CC; Kastner DL; Torrelo A; Zlotogorski A; Moir S; Gadina M; McCoy P; Wesley R; Rother KI; Hildebrand PW; Brogan P; Krüger E; Aksentijevich I; Goldbach-Mansky R
J Clin Invest; 2015 Nov; 125(11):4196-211. PubMed ID: 26524591
[TBL] [Abstract][Full Text] [Related]
6. Proteasome disorders and inborn errors of immunity.
Poli MC
Immunol Rev; 2024 Mar; 322(1):283-299. PubMed ID: 38071420
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic insights from genetic causes of autoinflammatory inflammasomopathies and interferonopathies.
Lin B; Goldbach-Mansky R
J Allergy Clin Immunol; 2022 Mar; 149(3):819-832. PubMed ID: 34893352
[TBL] [Abstract][Full Text] [Related]
8. Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation.
Yan K; Zhang J; Lee PY; Tao P; Wang J; Wang S; Zhou Q; Dong M
Arthritis Rheumatol; 2022 Jun; 74(6):1083-1090. PubMed ID: 35080150
[TBL] [Abstract][Full Text] [Related]
9. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
Chiche L; Jourde-Chiche N; Whalen E; Presnell S; Gersuk V; Dang K; Anguiano E; Quinn C; Burtey S; Berland Y; Kaplanski G; Harle JR; Pascual V; Chaussabel D
Arthritis Rheumatol; 2014 Jun; 66(6):1583-95. PubMed ID: 24644022
[TBL] [Abstract][Full Text] [Related]
10. Disease course and treatment effects of a JAK inhibitor in a patient with CANDLE syndrome.
Boyadzhiev M; Marinov L; Boyadzhiev V; Iotova V; Aksentijevich I; Hambleton S
Pediatr Rheumatol Online J; 2019 May; 17(1):19. PubMed ID: 31046790
[TBL] [Abstract][Full Text] [Related]
11. Identification of eight novel proteasome variants in five unrelated cases of proteasome-associated autoinflammatory syndromes (PRAAS).
Papendorf JJ; Ebstein F; Alehashemi S; Piotto DGP; Kozlova A; Terreri MT; Shcherbina A; Rastegar A; Rodrigues M; Pereira R; Park S; Lin B; Uss K; Möller S; da Silva Pina AF; Sztajnbok F; Torreggiani S; Niemela J; Stoddard J; Rosenzweig SD; Oler AJ; McNinch C; de Guzman MM; Fonseca A; Micheloni N; Fraga MM; Perazzio SF; Goldbach-Mansky R; de Jesus AA; Krüger E
Front Immunol; 2023; 14():1190104. PubMed ID: 37600812
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and type I interferon-regulated genes and chemokines mark disease activity in dermatomyositis.
Bilgic H; Ytterberg SR; Amin S; McNallan KT; Wilson JC; Koeuth T; Ellingson S; Newman B; Bauer JW; Peterson EJ; Baechler EC; Reed AM
Arthritis Rheum; 2009 Nov; 60(11):3436-46. PubMed ID: 19877033
[TBL] [Abstract][Full Text] [Related]
13. Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases.
de Jesus AA; Hou Y; Brooks S; Malle L; Biancotto A; Huang Y; Calvo KR; Marrero B; Moir S; Oler AJ; Deng Z; Montealegre Sanchez GA; Ahmed A; Allenspach E; Arabshahi B; Behrens E; Benseler S; Bezrodnik L; Bout-Tabaku S; Brescia AC; Brown D; Burnham JM; Caldirola MS; Carrasco R; Chan AY; Cimaz R; Dancey P; Dare J; DeGuzman M; Dimitriades V; Ferguson I; Ferguson P; Finn L; Gattorno M; Grom AA; Hanson EP; Hashkes PJ; Hedrich CM; Herzog R; Horneff G; Jerath R; Kessler E; Kim H; Kingsbury DJ; Laxer RM; Lee PY; Lee-Kirsch MA; Lewandowski L; Li S; Lilleby V; Mammadova V; Moorthy LN; Nasrullayeva G; O'Neil KM; Onel K; Ozen S; Pan N; Pillet P; Piotto DG; Punaro MG; Reiff A; Reinhardt A; Rider LG; Rivas-Chacon R; Ronis T; Rösen-Wolff A; Roth J; Ruth NM; Rygg M; Schmeling H; Schulert G; Scott C; Seminario G; Shulman A; Sivaraman V; Son MB; Stepanovskiy Y; Stringer E; Taber S; Terreri MT; Tifft C; Torgerson T; Tosi L; Van Royen-Kerkhof A; Wampler Muskardin T; Canna SW; Goldbach-Mansky R
J Clin Invest; 2020 Apr; 130(4):1669-1682. PubMed ID: 31874111
[TBL] [Abstract][Full Text] [Related]
14. Expression of interferon-regulated genes in juvenile dermatomyositis versus Mendelian autoinflammatory interferonopathies.
Kim H; Gunter-Rahman F; McGrath JA; Lee E; de Jesus AA; Targoff IN; Huang Y; O'Hanlon TP; Tsai WL; Gadina M; Miller FW; Goldbach-Mansky R; Rider LG
Arthritis Res Ther; 2020 Apr; 22(1):69. PubMed ID: 32252809
[TBL] [Abstract][Full Text] [Related]
15. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
[TBL] [Abstract][Full Text] [Related]
16. JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies.
Sanchez GAM; Reinhardt A; Ramsey S; Wittkowski H; Hashkes PJ; Berkun Y; Schalm S; Murias S; Dare JA; Brown D; Stone DL; Gao L; Klausmeier T; Foell D; de Jesus AA; Chapelle DC; Kim H; Dill S; Colbert RA; Failla L; Kost B; O'Brien M; Reynolds JC; Folio LR; Calvo KR; Paul SM; Weir N; Brofferio A; Soldatos A; Biancotto A; Cowen EW; Digiovanna JJ; Gadina M; Lipton AJ; Hadigan C; Holland SM; Fontana J; Alawad AS; Brown RJ; Rother KI; Heller T; Brooks KM; Kumar P; Brooks SR; Waldman M; Singh HK; Nickeleit V; Silk M; Prakash A; Janes JM; Ozen S; Wakim PG; Brogan PA; Macias WL; Goldbach-Mansky R
J Clin Invest; 2018 Jul; 128(7):3041-3052. PubMed ID: 29649002
[TBL] [Abstract][Full Text] [Related]
17. [When to consider type I interferonopathy in adulthood?].
David C; Frémond ML
Rev Med Interne; 2022 Jun; 43(6):347-355. PubMed ID: 35177256
[TBL] [Abstract][Full Text] [Related]
18. Three Copies of Four Interferon Receptor Genes Underlie a Mild Type I Interferonopathy in Down Syndrome.
Kong XF; Worley L; Rinchai D; Bondet V; Jithesh PV; Goulet M; Nonnotte E; Rebillat AS; Conte M; Mircher C; Gürtler N; Liu L; Migaud M; Elanbari M; Habib T; Ma CS; Bustamante J; Abel L; Ravel A; Lyonnet S; Munnich A; Duffy D; Chaussabel D; Casanova JL; Tangye SG; Boisson-Dupuis S; Puel A
J Clin Immunol; 2020 Aug; 40(6):807-819. PubMed ID: 32572726
[TBL] [Abstract][Full Text] [Related]
19. Correlation of cutaneous disease activity with type 1 interferon gene signature and interferon β in dermatomyositis.
Huard C; Gullà SV; Bennett DV; Coyle AJ; Vleugels RA; Greenberg SA
Br J Dermatol; 2017 May; 176(5):1224-1230. PubMed ID: 27564228
[TBL] [Abstract][Full Text] [Related]
20. Precision treatment of Singleton Merten syndrome with ruxolitinib: a case report.
Broser P; von Mengershausen U; Heldt K; Bartholdi D; Braun D; Wolf C; Lee-Kirsch MA
Pediatr Rheumatol Online J; 2022 Apr; 20(1):24. PubMed ID: 35410415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
